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Summary: Acute intermittent porphyria is a genetic disorder of haem biosynthesis caused by defects in the gene
encoding hydroxymethylbilane synthase on the long arm of chromosome 11. Every effort should be made to identify
gene carriers amongst the relatives of patients known to have acute intermittent porphyria s they are at risk of
developing potentially fatal neurogenic attacks if exposed to precipitating factors. Erythrocyte hydroxymethylbilane
synthase activity was determined in 46 members of two large well characterised families by assaying enzyme
activity by both high performance liquid chromatography (HPLC) and fluorimetric assays. Additionally, hydroxy-
methylbilane synthase immunoreactivity was determined by a sandwich-type ELISA. Statistically significant corre-
lations were observed between erythrocyte hydroxymethylbilane synthase activity assayed by HPLC and by the
fluorimetric assay, and enzyme protein concentration (r = 0.85, p < 0.001 and r = 0.80, p < 0.001, respectively).
The assay of hydroxymethylbilane synthase immunoreactive concentration in erythrocytes was useful in excluding
acute intermittent porphyria in one patient in whom unequivocal assignment of porphyric Status was not possible
by assaying enzyme activity alone. Erythrocyte hydroxymethylbilane synthase activity assayed by HPLC and fluo-
rimetry showed approximately equal diagnostic performances, both giving rise to a dichotomic distribution of
values, with overlap zones of 6% (1/16) and 22% (2/9), respectively, at the "cut off' applied.
Introduction should be made to identify gene carriers amongst the
, . . i j · relatives of patients known to have acute intermittentAcute intermittent porphyria is an autosomal dominant . ^, " " t f : . . , . , , j . porphyria (5). Normal haem precursors usually occur mdisorder of haem biosynthesis in which over-production r J ^ ' r_-, . j ... - . . ,. ,. asymptomatic gene camers. Furthermore, normal por-ofhaemprec rsofsisassociatedwithcharactensticchn- / Λ . . . . ., F
. , ' , · 11 .r i u· * · phynn excretion may occur in known patients with acuteical features and potentially fatal neuropsychiatnc syn- . . t . _ . . . . , ,_ .j /ι ο\" Ά * · * ·«. * u · · A u intermittent porphyna dunng the remission penods (6).drome (l, 2). Acute intermittent porphyna is caused by , / , , „ ., , . .
defects in the gene eneodmg hydroxymethylbilane syn- Low ^hrocyte hydroxymethylb ane synthase activaty
thase (EC 4.3.1.8),') also known s poiphobilinogen de- 1S ^c.fically diagnost,c of acute mtermittent porphyna
aminase (3). Hydroxymethylbilane synthase is a cyto- &> 7> and remains the most effectiv6 method for detect-
solic enzyme and has reduced activity in abnormal gene ing gene carriers (8» 9>- Nevertheless, unequivocal s-
„o . ,0 A^ signment confirming or refuting the diagnosis of acutecamers \y·,. *·/·
intermittent porphyria cannot be achieved among some
It is important to investigate asymptomatic individuals reiatives of a known patient with acute intermittent por-
for latent or subclinical poφhyria and every eifort phyria due to the overiap in enzyme activities between
affected patients and normal subjects (8—10).
) Enzyme: Wrtwtl Q0 „ΛΓηι,Λκ;ΐίηο«ι»η Α* Molecular heterogeneity in acute intermittent porphyriaHydfoxymethylbilane synthase also known s porpnobilmogen de- ° J \ ̂
aminase (BC 4.3.1.8) 00 and ^e large number of pomt mutations (12—14)
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detected so far, make genetic studies in affected families
an impractical Option at the present time. None of the
mutations so far identified has been found to occur more
frequently than any of the others, and many of these
mutations appear to be unique to one family. Addition-
ally, all polymorphic sites are clustered within a small
fragment (1.5 X l O3 bases in the first intron) of the hy-
droxymethylbilane synthase gene and thus limiting the
usefulness of restriction fragment length polymorphisms
in identifying and differentiating the mutant allele frorn
the normal one (15). However, restriction fragment
length polymoφhisms have been successfully used for
haplotype analysis and heterozygote canier detection in
specific families with acute intermittent porphyria (16,
17).
In this study, the level of hydroxymethylbilane synthase
gene expression in erythrocytes was determined in two
large well characterised families by assaying hydroxy-
methylbilane synthase activity by both high performance
liquid chroniatography (HPLC) of the reaction products
(18), and by a fluorimetric assay (19). In addition, im-
munoreactive enzyme was assayed by ELISA (20). The
aim of this study was to assess the performance of as-
says measuring hydroxymethylbilane synthase activity,
to document the degree of overlap in enzyme activities
between gene camers and normal subjects using dif-
ferent methods, and secondly, to investigate whether de-
termination of hydroxymethylbilane synthase immuno-
reactivity and specific enzyme activities have a better




We studied 46 members from two large well characterised families:
33 members aged 2 to 70 years (mean ± SEM, 34.5 ± 3.4 years)
(19 females and 14 males) were investigated from family l (fig.
1), and 13 individuals aged 5 to 50 years (mean ± SEM, 28.2
± 4.4 years) (7 females and 6 males) from family 2 (flg. 2) were
studied.
Urinary and faecal porphyrin quantif icat ion
Urinary and faecal porphyrins were identified and quantified by
high performance liquid chromatography (HPLC) according to the
method of Lim & Peters (21). If acute porphyria was suspected,
urinary 5-aminolaevulinic aeid and pprphobilinogen excretion were
quantified after prior purification by anion-exchange chromatogra-
phy (22). · r
Erythrocyte hydroxymethylbilane synthase activity
Hydroxymethylbilane synthase activity was assayed by the HPLC
method of Wright & Lim (18) using fresh heparinised erythrocytes.
The enzyme activity was expressed s uroporphyrin, μηιοΐ/h · l
erythrocytes. The between^run coefficient of Variation was 8% at
a level of 25 uroporphyrin, μηιοΐ/h · l erythrocytes. Hydroxymeth^
ylbilane synthase activity was also determined by the fluorimetric
assay of Magnussen et al. (19) with the assay of haemoglobin in
the haemolysate (23). Enzyme activity was related to haemoglobin
concentration and expressed s pkat/g Hb. The between-run coeffi-
cients of Variation of the fluorimetric assay were 2.1% and 5.4%
for healthy and porphyric subjects, respectively. The lower refer-
ence limit applied was 90 pkat/g Hb, representing a diagnostic sen-
sitivity of 97% and a specificity of 85%. Non-^gene carriers do not
exhibit erythrocyte hydroxymethylbilane synthase activities below
70 pkat/g Hb, a value representing a "cut off' limit giving a sensi-
tivity of 100%, but a low specificity of 47% (24).
Erythrocyte hydroxymethylbilane synthase
concentration
Hydroxymethylbilane synthase concentration was assayed by a
sandwich-type ELISA with monospecific polyclonal antiserum
(IgG) raised against hydroxymethylbilane synthase, s previously
described (20). Haemoglobin concentration (absorbance read at
410 nm) of the samples was determined and hydroxymethylbilane
synthase concentration was expressed relative to haemoglobin con-
centration s μg/g Hb. Erythrocytes hydroxymethylbilane synthase
specific activity was determined by dividing enzyme activity with
enzyme protein concentration, and expressed s nkat/g enzyme
protein (20). A lower reference limit of 110 μg/g Hb was used.
This "cut off' Value gives a diagnostic sensitivity of 85% and spec-
ificity of 85% (24).
Further blood analyses
All patients had assays for f ll blood count, white cell differential
and subset assays. Biochemical profile including renal and liver
function and toxicity tests was carried-out on the DAX-48 multi-
channel analyser (Bayer Diagnostics, Basingstoke, UK) by Stan-
dard methods.
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Fig. l Pedigree of family l showing autosomal dominant inheri- tigated are represented by hatched Symbols (m ©). Patient 111:8, in
tance of acute intermittent porphyria. Affected individuals are rep- whom definitive porphyric Status was not possible, is represented
resented by black Symbols (H o), unaffected individuals are de- by half-filled Symbol (3). \ indicates propositus.
picted s open Symbols (D O), while members who were not inves- > ;
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 32, 1994/No. 12
Wassif et al.: Acute intermittent porphyria: Diagnostic conundrums 917
» Ώ-Γ&
Fig. 2 Pedigree of family 2 showing autosomal dominant inheri-
tance of acute intermittent porphyria. Affected individuals are rep-
resented by black Symbols (D 0), unaffected individuals are de-
picted s open Symbols (G O), while members who were not inves-
tigated are represented by hatched Symbols (@ ©). \ indicates pro-
positus.
Results
In the two families the propositus (patient III: 15, fig. 1;
patient 111:2, fig. 2) presented at the age of 34 and 27
years, respectively, with a history of dieting prior to hos-
pital admission. Both index patients were admitted to
hospital with severe abdominal pain, hypertension, vom-
iting and constipation and had elevated urinary excretion
of 5-aminolaevulinic acid, porphobilinogen, raised uri-
nary porphyrin and normal faecal porphyrin (tab. 1). The
decreased red cell hydroxymethylbilane synthase activ-
ity in both patients (assayed by HPLC, tab. 1) was con-
sistent with the diagnosis of acute intermittent por-
phyria.
Assay of erythrocyte hydroxymethylbilane synthase ac-
tivity (by the HPLC technique) in 33 members of family
l (fig. 1) identified 11 (33%) individuals s gene carri-
ers. Twenty one family members did not inherit the gene
defect. In one individual (patient 111:8, fig. 1) unequivo-
cal assignment confirming or reiuting the diagnosis of
acute intermittent porphyria was not possible by assay
of hydroxymethylbilane synthase activity alone due to
the overlap in enzyme activities between affected pa-
tients and normal subjects (8—10). Of 13 members of
family 2 (fig. 2) 4 (31%) patients were identified s gene
carriers. There was no overlap in enzyme activity in
family 2 and unequivocal assignment excluding acute
intermittent porphyria was possible in the other 9 family
members. All gene carriers in both families, with the
exception of the two index patients, had urinary and fae-
cal porphyrins and urinary 5-aminolaevulinic acid and
porphobilinogen within the reference ranges. Of 15 gene
carriers, only 2 (13%) patients (patient 111:15, fig. 1; pa-
tient 111:2, fig. 2) developed attacks of acute intermit-
tent porphyria.
To charaeterize further the defect in acute intermittent
porphyria, and establish a definitive diagnosis in the
subjects with equivocal hydroxymethylbilane synthase
activity, 22 members (11 from each family) were sub-
jected to further investigations including the measure-
ment of hydroxymethylbilane synthase immunoreactive
Tab. l Urinary 5-aminolaevulinic acid and porphobilinogen
excretion, urinary and faecal porphyrins pattern and erythrocyte
hydroxymethylbilane synthase activity in the two index patients.
Hydroxymethylbilane synthase activity was assayed by the method
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concentration. Additionally, enzyme activity was inea-
sured by the independent fluorimetric assay described
by Magnussen et al. (19) and specific enzyme activity
was determined. Of the 22 subjects 8 had been classified
s gene carriers by the HPLC method, 13 were normal
and not at risk of acute intermittent porphyria, and in
one member porphyric Status was questionable s eryth-
rocyte hydroxymethylbilane synthase activity was
equivocal s shown in table 2. Seven out of eight in-
dividuals diagnosed s gene carriers by the HPLC
method were identified s such by the fluorimetric assay.
One individual given the diagnosis of acute intermittent
porphyria by the HPLC method, exhibited a value just
above the reference value applied when erythrocyte hy-
droxymethylbilane synthase activity was assayed by the
fluorimetric assay, s did the individual exhibiting
equivocal result in the HPLC assay. Thus both assays
show similar diagnostic efficiency and give rise to a rel-
atively clear-cut dichotomic distribution of gene carriers
and non-carriers (flg. 3).
It is clear from table 2 that all gene carriers had hydro-
xymethylbilane synthase concentrations below 110 μg/g
Hb. The measurement of hydroxymethylbilane synthase
concentration in erythrocytes was usefiil in excl ding
aeute intermittent porphyria in patient 111:8 (fainily l,
flg. l, tab. 2) who had equivocal enzyme activity using
the HPLC assay but had hydroxymethylbilane synthase
concentration of 125 μ^/g Hb. However, there was one
overlap in hydroxymethylbilane synthase concentration
in a normal subjeet (subject 111:8, family 2, flg. 2, tab.
2) who did not inherit the gene defect but had hydroxy-
methylbilane synthase concentration of 90 μξ/g Hb. As
shown in table 2, hydroxymethylbilane synthase specific
actiivty was not helpful in identifying patients at risk
of acute intermittent porphyria and there was no clear
Separation in enzyme specific activity between gene car-
riers and normal subjects. Indeed, there was no correla-
tion between hydroxymethylbilane synthase specific ac^
tivity and both enzyme activity and enzyme concentra-
tion (r = 0.42, p = 0.06 and r = 0.14, p = 0.52, respec-
Tab. 2 Erythrocyte hydroxymethylbilane synthase activity, concentration and specific activity in the
two families with acute intermittent porphyria.
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Fig. 3 Erythrocyte hydroxymethylbilane synthase activity and
concentration in two families with acute intermittent porphyria.
Hydroxymethylbilane synthase activities were determined by the
HPLC method of Wright & Lim18 and the fluorimetric method of
Magmissen et al.19. Carrier Status was arbitrarily assigned using
the HPLC assay data. The lower limits of the reference ranges of
various assays are represented with solid lines. Gene carriers (o),
non carriers (O) and equivocal Status ( ). / indicates propositus.
tively). In contrast, statistically significant correlations
were observed between erythrocyte hydroxymethylbi-
lane synthase activity assayed by the method of
Wright & Lim and enzyme activity determined by the
method of Magnussen et al., and enzyme concentration
(r = 0.85, p < 0.001 and r = 0.80, p < 0.001 respec-
tively, n = 22). A highly significant correlation was also
observed between erythrocyte hydroxymethylbilane
synthase activity assayed according to the method of
Magnussen et al. and hydroxymethylbilane synthase
concentration (r = 0.96, p < 0.001, n = 22).
All members investigäted from both families had normal
biochemical profiles and haematological indices except
2 gene carriers from fämily 2 (patients 111:6 and IV:2,
fig. 2) who had iron deficiency anaemia and a repeat
hydroxymethylbilane synthase activity was performed
after iron replacement therapy.
Discussion
The elevated urinary excretion of 5-aijiinolaevulinic acid
and porphobilinogen in both index patients is consistent
with the diägiiosis of one of the acute pörphyrias (i. e.,
acute intermittent porphyria, variegate porphyria and he-
reditary coproporphyria). The raised urinary porphyrin
content (tab. 1) has probably arisen by non-enzymic po-
lymerization of po hobilinogen in the urine to form a
mixture of uropo hyrin isomers. The normal faecal por-
phyrin excretion in both patients indicates that variegate
porphyria and hereditary coproporphyria are highly uft-
likely, whereas the decreased red cell hydroxymethylbi-
lane synthase activity (tab. 1) is consistent with acute
intermittent porphyria.
The dominant mode of inheritance, the occurrence of
asymptomatic gene carriers and the risk of developing
potentially fatal attacks if exposed to a wide ränge of
common precipitating factors, make it essential to ex-
clude or confirm the diagnosis of acute intermittent por-
phyria in all relatives whenever the diagnosis has been
made in one member of the fämily (2, 7). Patients with
acute intermittent porphyria are at risk of developing
potentially fatal neurogenic attacks if exposed to exoge-
nous precipitating factors including a wide ränge of
commonly prescribed drugs (25), alcohol, fasting, stress,
hormones (2, 26) and, interestingly, if they continue to
smoke (27). In our study, the index patients in both fam-
ilies had acute attacks of porphyria following low calo-
rie diet for weight reduction.
In our haads the HPLC and fluorimetric assays for
erythrocyte hydroxymethylbilane synthase activity
showed about the same diagnostic efficiency at the "cut
off" levels applied, 8 and 7 individuals, respectively,
diagnosed äs gene carriers. However, it is clear that,
whichever assay is used, there was a small overlap be-
tween enzyme activities in normal subjects and gene
carriers in our study äs in previous studies (8—10). It is
well established that a definitive assignment of porph-
yric Status cannot always be made in all relatives, even
when porphobilinogen excretion, 5-aminolaevulinic acid
synthase activity (28) and gene dosage effect (9) are
taken into account. Lamon et al. demonstrated that pedi-
gree analysis with respect to Üie frequency distribution
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 32,1994 / No. 12
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of hydroxymethylbilane synthase enzyme activities in
family members was successful in establishing porph-
yric Status in 50% of those subjects with equivocal en-
zyme activity (9). It is noteworthy that the existence of a
variant of acute intermittent po hy ia has been reported
where enzyme defect is not expressed in erythrocytes
(29), in such families the measurement of erythrocyte
hydroxymethylbilane synthase activity is unhelpful.
In this study, the measurement of erythrocyte hydroxy-
methylbilane synthase immunoreactive concentration
was useful in excluding the diagnosis of acute intermit-
tent pörphyria in one member who had equivocal hydro-
xymethylbilane synthase activity. The estimatiorl of en-
zyme specific activity was not useful in identifying gene
carriers with no clear Separation between normal sub-
jects and gene carriers. This is hardly surprising since
there is a good correlation between hydroxymethylbi-
lane synthase activity and enzyme protein concentration.
This indicates that in these two families there is either
no gene product or that the protein produced is neither
catalytically active nor recognised by the anti-serum
used in the ELISA, i. e., we are dealing with a form of
acute intermittent pörphyria in whicfa no cross reacting
immunoreactive material (CRIM) is iproduced (GRIM
negative). Since hydroxymethylbilane synthase activity
decreases äs red cells age any shift in their age distribu-
tion will be reflected in the enzyme activity (5), a repeat
of hydroxymethylbilane synthase activity was essential
in the two suspected gene carriers after the correction of
the haematological abnormälities.
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